FDA Warns Cosmetics Co. on Possible Seizure, Etc. for FFDCA Marketing Violation
The Food and Drug Administration has issued a warning letter to Refine USA, LLC regarding its marketing of the VeinGogh Ohmic Thermolysis System without marketing clearance or approval, in violation of the Federal Food, Drug, and Cosmetic Act. FDA states…
Sign up for a free preview to unlock the rest of this article
If your job depends on informed compliance, you need International Trade Today. Delivered every business day and available any time online, only International Trade Today helps you stay current on the increasingly complex international trade regulatory environment.
that failure to promptly correct the violations may result in regulatory action being initiated, including, but not limited to, seizure, injunction, and/or civil penalties.